Patent · US Active

Imidopiperidine compounds as inhibitors of human polynucleotide kinase phosphatase

US11325905B2 · kind B2 · utility

0Cited by
0References
15Claims
0Family size

Assignee

Inventors

Key dates

Filing dateApr 5, 2018
Grant dateMay 10, 2022
Priority date—
Expiry dateApr 5, 2038

Classification

  • Technology area (CPC A)Human Necessities
  • CPC primaryA61K31/4745
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

There is described herein imidopiperidine compounds as inhibitors of human polynucleotide kinase phosphatase.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.